GAITHERSBURG, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 9:00 a.m. Eastern time. The conference will be held at the Wyndham Grand Hotel in Jupiter, Florida on October 18-19, 2017.
In addition, Mr. Jones will participate on a panel discussion titled "The Convergence of Artificial Intelligence and Healthcare: New Developments in Precision Medicine” on Wednesday, October 18, 2017 at 5:00 p.m. Eastern time.
To listen to the corporate presentation live, investors may visit the investor relations section of OpGen, Inc.’s website at www.opgen.com. An archived webcast of the presentation will also be available on OpGen’s website for a period of time.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.
OpGen®, Acuitas®, Acuitas Lighthouse® and QuickFISH® are registered trademarks of OpGen, Inc.
OpGen Contact:
Michael Farmer
Sr. Director, Marketing
240-813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
Investor Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com